Sanofi gets EC approval for recombinant influenza vaccine Supemtek
The EC authorisation is based on clinical data from two Phase 3 trials in a total of more…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Nov 20
The EC authorisation is based on clinical data from two Phase 3 trials in a total of more…
18 Nov 20
The FDA breakthrough therapy designation is based on results from a randomised, multicentre, double-blind Phase 2b/3 study HPTN…
16 Nov 20
Xofluza is an advanced antiviral, designed to inhibit the cap-dependent endonuclease protein, which is essential for viral replication
10 Nov 20
NVX-CoV2373 is being studied under Phase 3 clinical trial in the UK, with additional trials planned in the…
06 Nov 20
The maintenance treatment using the drug regimen reduced the risk of disease progression or death by 67%, and…
03 Nov 20
Tecentriq plus Avastin is the first and only approved cancer regimen for unresectable hepatocellular carcinoma (HCC) in Europe
02 Nov 20
Adakveo is claimed to be the first targeted sickle cell disease therapy for prevention of recurrent vaso-occlusive crises…
30 Oct 20
GSK said that Zejula is the first monotherapy for patients with platinum-responsive advanced ovarian cancer in the European…
28 Oct 20
Pfizer’s regulatory filing for abrocitinib is based on clinical trial data showing improvement in symptoms, along with a…
23 Oct 20
Veklury becomes the first and only FDA approved treatment for Covid-19 in the US, which helps recovery of…